Half-year report · HY
6315.TEDINET S100X067
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥53.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥27.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥2.5bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥5.3bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.2bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.5bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥5.2bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.8bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥3.8bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥91.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥83.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥84.9bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥27.2bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥21.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥63.8bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥61.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥59.0bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥24.5bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥22.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.3bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.5bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥10.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.9bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥24.66 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.28 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.02 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 70.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| Laser Processing Machinesreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥640m |
| Laser Processing Machinesreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥640m |
| Laser Processing Machinesreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥82m |
| Medical Devicereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.2bn |
| Medical Devicereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.2bn |
| Medical Devicereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥225m |
| Semiconductor Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥21.6bn |
| Semiconductor Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥21.6bn |
| Semiconductor Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.4bn |
| Laser Processing Machinesreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥955m |
| Laser Processing Machinesreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥955m |
| Laser Processing Machinesreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥42m |
| Medical Devicereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Medical Devicereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Medical Devicereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥240m |
| Semiconductor Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥25.3bn |
| Semiconductor Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥25.3bn |
| Semiconductor Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥5.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 502
| Item | Context | Value | Unit |
|---|---|---|---|
| Salaries and allowances sga | Prior1InterimDuration | 1347081000 | JPY |
| Salaries and allowances sga | InterimDuration | 1410685000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 359640000 | JPY |
| Provision for bonuses sga | InterimDuration | 366628000 | JPY |
| Provision for directors bonuses sga | Prior1InterimDuration | 30166000 | JPY |
| Provision for directors bonuses sga | InterimDuration | 29555000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 28347000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 35314000 | JPY |
| Provision for share based remuneration sga | Prior1InterimDuration | 7048000 | JPY |
| Provision for share based remuneration sga | InterimDuration | 11600000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 25314874000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E01708-000MedicalDeviceReportableSegmentsMember | 1129068000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E01708-000LaserProcessingMachinesReportableSegmentsMember | 954807000 | JPY |
| Revenues from external customers | Prior1InterimDuration | 27398749000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E01708-000SemiconductorEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E01708-000MedicalDeviceReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E01708-000LaserProcessingMachinesReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 25314874000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E01708-000MedicalDeviceReportableSegmentsMember | 1129068000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E01708-000LaserProcessingMachinesReportableSegmentsMember | 954807000 | JPY |
| Net sales | Prior1InterimDuration | 27398749000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 5063208000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E01708-000MedicalDeviceReportableSegmentsMember | 240059000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E01708-000LaserProcessingMachinesReportableSegmentsMember | -41568000 | JPY |
| Operating income | Prior1InterimDuration | 5261699000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 21585649000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E01708-000MedicalDeviceReportableSegmentsMember | 1224106000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E01708-000LaserProcessingMachinesReportableSegmentsMember | 640139000 | JPY |
| Revenues from external customers | InterimDuration | 23449896000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E01708-000SemiconductorEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E01708-000MedicalDeviceReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E01708-000LaserProcessingMachinesReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 21585649000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E01708-000MedicalDeviceReportableSegmentsMember | 1224106000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E01708-000LaserProcessingMachinesReportableSegmentsMember | 640139000 | JPY |
| Net sales | InterimDuration | 23449896000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 2350817000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E01708-000MedicalDeviceReportableSegmentsMember | 225010000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E01708-000LaserProcessingMachinesReportableSegmentsMember | -82249000 | JPY |
| Operating income | InterimDuration | 2493577000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-11-10 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第48期中（自 2025年４月１日 至 2025年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ＴＯＷＡ株式会社 | |
| Company name in english cover page | FilingDateInstant | TOWA CORPORATION | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)取締役社長執行役員 三浦 宗男 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |